Myomo(MYO) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Myomo Reports Second Quarter 2025 Financial and Operating Results Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance Conference call begins today at 4:30pm Eastern time BURLINGTON, Mass. (August 11, 2025) – Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the ...